5-Phenyl-2,4-pentadien-1-amines and method for inhibiting prosta

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2605708R, 424309, 424311, 424319, 424330, A61K 31275, A61K 3124, A61K 31195, A61K 31135

Patent

active

041736494

ABSTRACT:
5-Phenyl-2,4-pentadien-1-amines and salts thereof are provided having the structure ##STR1## wherein R.sup.1 is hydrogen, lower alkyl, lower alkoxy, hydroxy, lower alkanoyloxy, nitro, cyano, amino, carboxy or lower alkoxycarbonyl, and R.sup.2 and R.sup.3 are the same or different and are hydrogen, lower alkyl, alkenyl-lower alkyl, aralkyl, and substituted lower alkyl. These compounds possess useful pharmceutical activites due to their ability to inhibit the prostaglandin-inactivating enzyme 15-.alpha.-hydroxyprostaglandin dehydrogenase.

REFERENCES:
patent: 3094561 (1963-06-01), Sundeen et al.
Dimmock et al.-J. of Pharm. Sci., vol. 63, #1, Jan. 1974, pp. 69-74; vol. 65, #4, Apr. 1976, 483-8.
Gschwend et al., J. Org. Chem. 38, 2169 (1973).
Peskar et al.-J. Pharm. Pharmac., 1976, 28, 146.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

5-Phenyl-2,4-pentadien-1-amines and method for inhibiting prosta does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-Phenyl-2,4-pentadien-1-amines and method for inhibiting prosta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-Phenyl-2,4-pentadien-1-amines and method for inhibiting prosta will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-462439

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.